Why Phase I Clinical Trials Succeed with Medrio

Phase I clinical trials represent a major milestone in a new medical product’s journey from lab to market. With the product now being tested in humans for the first time, the insights gathered in these studies play a key role in determining its viability as a new treatment that can improve public health.

Medrio is known throughout the clinical research industry for understanding the needs of sponsors, CROs, and Research Centers conducting Phase I studies, and empowering them to meet and exceed their goals in these pivotal trials. So what do Phase I researchers achieve with Medrio’s eClinical tools?


Speed. Flexibility. Efficiency.

  • Make mid-study changes easily
    Mid-study changes are common in Phase I studies, and researchers need a seamless and efficient way tohandle them. In Medrio, you can make mid-study changes without vendor reliance, downtime, database migrations, or fees from Medrio.
  • Build studies in days, not months
    Inefficiencies in the early phases can set the tone for the whole research process, possibly delaying FDA submission and market arrival. With no reliance on programming for eCRF build, Medrio users can build their studies with efficiency, control and – most importantly – speed.
  • Reuse configuration and save time
    Though different Phase I studies have different characteristics, many use similar designs. With Medrio, you can copy forms and even entire databases from previous studies and use them in your next one. Why start from scratch just to rebuild what you essentially already have?
  • Protect patient safety
    Medrio eSource empowers you to enter data in real time and detect safety signals quickly – an essential capability in Phase I, where the safety profile of the product is still not fully known.
  • Access lots of other benefits
    From event- and subject-based navigation, to eLearning videos for site staff and other users, to low pricing for smaller studies and beyond, Medrio users benefit from a wide array of features – not just in Phase I, but across all study types.

Medrio empowers sponsors and CROs in all phases of clinical research to accelerate their processes and reduce costs. But it’s our Phase I users who truly see the benefits of getting a strong eClinical start as a product begins its journey to market.


About Medrio

Founded in 2005, Medrio is a leading healthcare technology company providing eClinical solutions including EDC, eSource, and ePRO for clinical research. The company’s cloud-based software platform and mobile suite of products deliver fast, flexible, and easy-to-use tools for the collection and management of clinical data and patient-reported outcome responses. Study sponsors and contract research organizations have used Medrio extensively across drug, device, diagnostic, and animal health trials. Medrio has extensive experience in all study phases and leads the market in early-phase trials. The company serves over 500 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations. For more information about Medrio’s cloud-based EDC solutions for clinical research, visit www.medrio.com , email us at info@medrio.com , or call us at +1 800-498-6830.